ENTITY
Haw Par Corporation

Haw Par Corporation (HPAR SP)

58
Analysis
Health Care • Singapore
Haw Par Corporation Limited is a Singaporean multinational group involved in healthcare, investments, leisure, and property sectors. Its core business includes manufacturing and distributing topical analgesic products under the globally recognized Tiger Balm and Kwan Loong brands. The company was incorporated in 1969 and is based in Singapore.
more
bullish•Haw Par Corporation
•14 May 2019 00:00•Exchange-sponsored

Three Best-Performing Pharmaceutical Stocks Returned 23% in YTD

Singapore’s listed healthcare sector, as tracked by the benchmark iEdge SG All Healthcare Index, comprises companies that operate in the...

Share
•09 May 2019 00:00•Exchange-sponsored

Highlights of Home-Grown Family Empires on SGX

SGX lists at least 24 companies and two trusts associated with seven business empires run by some of Singapore’s richest families, and they...

Share
•09 Jan 2019 00:00•Exchange-sponsored

Healthcare Sector’s Growth Prospects Draw Fund Flows

Singapore’s healthcare sector is typically viewed as defensive and poised to enjoy multi-year growth prospects. Between July and Dec 2018, the...

Share
bullish•Haw Par Corporation
•26 Jun 2018 15:23•Exchange-sponsored
Share
bullish•Haw Par Corporation
•01 Mar 2018 08:00•Issuer-paid

Slow Quarter

For the fourth quarter ended December 2017, Haw Par reported revenue of SG$48 mn, up 2.2% YoY. Gross profit increased by 3.9% YoY to 30.6 mn while...

Logo
199 Views
Share
x